IDERA PHARMACEUTICALS, INC. 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Feb 8, 2017
Insider Transaction Report
Form 4
YINGLING JONATHAN MICHAEL
SVP of Early Development
Transactions
- Award
Stock Option
2017-02-06+275,000→ 275,000 totalExercise: $1.55Exp: 2027-02-06→ Common Stock (275,000 underlying) - Award
Stock Option
2017-02-06+325,000→ 325,000 totalExercise: $1.55Exp: 2027-02-06→ Common Stock (325,000 underlying)
Footnotes (2)
- [F1]This option was granted under the Company's Stock Incentive Plan. The option vests with respect to 25% of the underlying shares on the first anniversary of the date of grant and the balance of the underlying shares vests in twelve equal quarterly installments following the first anniversary date of the date of grant.
- [F2]This option was not granted pursuant to any pre-existing equity plan of the Company. Instead, this option was made as an inducement grant pursuant to Nasdaq Listing Rule 5635(c)(4)in connection with the reporting person's appointment as Senior Vice President, Early Development. The options vest with respect to 25% of the underlying shares on the first anniversary date of the date of grant and the balance of the underlying shares vests in twelve quarterly installments following the first anniversary of the date of grant.